Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
Pfizer's top-line growth is challenged by steep declines in COVID product sales and upcoming loss of exclusivity for key drugs like Eliquis and Ibrance. The $7B Metsera acquisition stretches Pfizer's balance sheet, limiting future buybacks and major acquisitions while aiming to offset revenue declines. Investors should expect modest returns, primarily from dividends, as Pfizer navigates LOE risks, cost savings initiatives, and a competitive obesity drug market. Massimo Giachetti/iStock Editorial via Getty Images It has been half a year since I published my last article about the pharmaceutical company Pfizer Inc. ( PFE ). In my last article I was rather bullish about the stock, and This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeki
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer (PFE) CEO Isn't Ready For A Fight With RFK Jr., Says Jim Cramer [Yahoo! Finance]Yahoo! Finance
- Trump's New Prescription Plan vs. Mark Cuban's: Experts Weigh In [Yahoo! Finance]Yahoo! Finance
- Small Molecule API Market Size to Reach USD 328.03 Billion by 2033, Driven by Rising Demand for Cost-Effective Therapeutics – SNS Insider [Yahoo! Finance]Yahoo! Finance
- What's in the Trump health care plan? White House releases blueprint. [USA TODAY]USA TODAY
- Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30 [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 1/16/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- PFE's page on the SEC website